Glymphatic dysfunction and neurodegeneration in ALS: Longitudinal insights from rNLS8 TDP-43 mice

Dysfunctional Tar DNA binding protein-43 (TDP-43) is found in approximately 95 % of all people with amyotrophic lateral sclerosis (ALS). Recent evidence suggests that the glymphatic system, which clears the brain of waste proteins, is impaired in ALS and may contribute to the accumulation of TDP-43....

Full description

Saved in:
Bibliographic Details
Main Authors: Akram Zamani, Adam K. Walker, David K. Wright
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996125000488
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199546215432192
author Akram Zamani
Adam K. Walker
David K. Wright
author_facet Akram Zamani
Adam K. Walker
David K. Wright
author_sort Akram Zamani
collection DOAJ
description Dysfunctional Tar DNA binding protein-43 (TDP-43) is found in approximately 95 % of all people with amyotrophic lateral sclerosis (ALS). Recent evidence suggests that the glymphatic system, which clears the brain of waste proteins, is impaired in ALS and may contribute to the accumulation of TDP-43. This study extends this work to investigate how glymphatic function changes over time in the rNLS8 doxycycline (Dox)-dependent TDP-43 mouse model of ALS. Motor function, advanced MRI biomarkers of neurodegeneration, and cortical glymphatic pathway gene expression were assessed together with dynamic contrast-enhanced MRI (DCE-MRI) assessment of glymphatic function at 0-, 3-, 7-, and 21-days after removing mice from Dox feed to initiate cytoplasmic human TDP-43 expression. A trend toward increased glymphatic influx was observed at 3-days post-Dox, together with MRI evidence of brain changes that occurred in the absence of hind-limb clasping and motor impairment. Glymphatic flow is facilitated by aquaporin-4 (AQP4) water channels polarized to astrocytic end feet. We found that while glymphatic function normalized to control levels at 7-days post-Dox, AQP4 expression in the cortex was significantly decreased. After 3-weeks of human TDP-43 expression, glymphatic dysfunction, weight loss, neurodegeneration, motor impairments and astrogliosis were observed. Our findings highlight early glymphatic dysfunction in ALS, suggesting its potential as a therapeutic target.
format Article
id doaj-art-040cb5a0e32b4d59a9d4a05fb190370f
institution Kabale University
issn 1095-953X
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj-art-040cb5a0e32b4d59a9d4a05fb190370f2025-02-08T04:59:34ZengElsevierNeurobiology of Disease1095-953X2025-03-01206106832Glymphatic dysfunction and neurodegeneration in ALS: Longitudinal insights from rNLS8 TDP-43 miceAkram Zamani0Adam K. Walker1David K. Wright2Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC 3004, AustraliaQueensland Brain Institute, The University of Queensland, QLD 4072, Australia; Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW 2006, AustraliaDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia; Corresponding author at: Department of Neuroscience, The School of Translational Medicine, Monash University, The Alfred Centre, 99 Commercial Road, VIC 3004, Australia.Dysfunctional Tar DNA binding protein-43 (TDP-43) is found in approximately 95 % of all people with amyotrophic lateral sclerosis (ALS). Recent evidence suggests that the glymphatic system, which clears the brain of waste proteins, is impaired in ALS and may contribute to the accumulation of TDP-43. This study extends this work to investigate how glymphatic function changes over time in the rNLS8 doxycycline (Dox)-dependent TDP-43 mouse model of ALS. Motor function, advanced MRI biomarkers of neurodegeneration, and cortical glymphatic pathway gene expression were assessed together with dynamic contrast-enhanced MRI (DCE-MRI) assessment of glymphatic function at 0-, 3-, 7-, and 21-days after removing mice from Dox feed to initiate cytoplasmic human TDP-43 expression. A trend toward increased glymphatic influx was observed at 3-days post-Dox, together with MRI evidence of brain changes that occurred in the absence of hind-limb clasping and motor impairment. Glymphatic flow is facilitated by aquaporin-4 (AQP4) water channels polarized to astrocytic end feet. We found that while glymphatic function normalized to control levels at 7-days post-Dox, AQP4 expression in the cortex was significantly decreased. After 3-weeks of human TDP-43 expression, glymphatic dysfunction, weight loss, neurodegeneration, motor impairments and astrogliosis were observed. Our findings highlight early glymphatic dysfunction in ALS, suggesting its potential as a therapeutic target.http://www.sciencedirect.com/science/article/pii/S0969996125000488Motor neuron diseaseProteinopathyWaste clearanceDiffusion weighted imaging
spellingShingle Akram Zamani
Adam K. Walker
David K. Wright
Glymphatic dysfunction and neurodegeneration in ALS: Longitudinal insights from rNLS8 TDP-43 mice
Neurobiology of Disease
Motor neuron disease
Proteinopathy
Waste clearance
Diffusion weighted imaging
title Glymphatic dysfunction and neurodegeneration in ALS: Longitudinal insights from rNLS8 TDP-43 mice
title_full Glymphatic dysfunction and neurodegeneration in ALS: Longitudinal insights from rNLS8 TDP-43 mice
title_fullStr Glymphatic dysfunction and neurodegeneration in ALS: Longitudinal insights from rNLS8 TDP-43 mice
title_full_unstemmed Glymphatic dysfunction and neurodegeneration in ALS: Longitudinal insights from rNLS8 TDP-43 mice
title_short Glymphatic dysfunction and neurodegeneration in ALS: Longitudinal insights from rNLS8 TDP-43 mice
title_sort glymphatic dysfunction and neurodegeneration in als longitudinal insights from rnls8 tdp 43 mice
topic Motor neuron disease
Proteinopathy
Waste clearance
Diffusion weighted imaging
url http://www.sciencedirect.com/science/article/pii/S0969996125000488
work_keys_str_mv AT akramzamani glymphaticdysfunctionandneurodegenerationinalslongitudinalinsightsfromrnls8tdp43mice
AT adamkwalker glymphaticdysfunctionandneurodegenerationinalslongitudinalinsightsfromrnls8tdp43mice
AT davidkwright glymphaticdysfunctionandneurodegenerationinalslongitudinalinsightsfromrnls8tdp43mice